Mp16-19 comparison of bcg to gemcitabine/docetaxel in the intermediate risk group composed mostly of tahgReuben Ben-David,Parissa Alerasool, Kaushik P. Kolanukuduru,Neeraja Tillu, Justin Eisenhauer,Nikhil Waingankar,Kyrollis Attalla,Reza Mehrazin,Peter Wiklund,John P. SfakianosJournal of Urology(2024)引用 0|浏览9暂无评分AI 理解论文溯源树样例生成溯源树,研究论文发展脉络Chat Paper正在生成论文摘要